📢Announcing HCC's 15th Support Group Meeting themed "Understanding Acute Myeloid Leukemia A Type of Blood Cancer" on Aug 17, 2024, 11:00 AM -12.00 PM IST. Please like & RT for the benefit of pts and caregivers in your network. Joining details below 📷👇

New Study Alert! Check out our latest publication on the Impact of the COVID-19 pandemic on AML Rx in India. This one-of-a-kind, data-rich study by HCC institutional members reveals a shift towards localized care, with patient outcomes remaining strong despite challenges. 💪📊

The hallmarks of cancer immune evasion: Cancer Cell cell.com/cancer-cell/fu…

Looks like NIH grant review panels have been suspended temporarily. Because it takes time to coordinate and schedule a multi-layered grant panel review from experts across the country, what seems like a short delay in review of funding applications could be the difference between

🇮🇳 Celebrating the 76th Republic Day of India! At HCC, we honor our nation’s legacy while driving forward with innovation and collaboration to improve outcomes in hematological cancers. Together, let’s build a brighter, healthier future! 🌟 #RepublicDayIndia #HematologyCares

When reports emerged in 2023 of T cell secondary malignancies in CAR-T treated pts, mechanism was unclear. New MSKCC report NEJM describes LV construct integration into TP53. Likely v rare event but does inform debate about using CAR-T early vs later. nejm.org/doi/full/10.10…

The potency of abnormal genetic fusion in chronic myeloid leukaemia in our latest study nature 👉🏽 nature.com/articles/s4158… This cancer is an oddity - one of the few single genetic “hit” cancers, a short trajectory (few years) from start to diagnosis, and explosive growth.

Roland-Garros narrated by Rafael Nadal. Chills 🥹

🧵👇Are you a clinician, researcher, or policymaker in hematological cancers? Then you should know about HCC. ➡️We’re a multi-center academic group powered by India’s top cancer institutions. ➡️Our mission? Build credible region-specific data that transforms care in blood cancers

At #CGCAnnual2024, Dr. Irene Ghobrial shared insights from the international PROMISE study— the international screening initiative focused on individuals at high risk for developing myeloma. 🎥 Watch: buff.ly/TjwlejI #CancerGenomics #Myeloma

As I write pars of my book, it strikes me that so little has been done in the science of science education in India. The impact of allyship in science. The experiences with mentorship. The study of the well-being of PhD scholars. Big gaps to be filled! 🙏🖋️📝